STACK_RATINGSby NERD_PROTOCOLS
< LEADERBOARD/s/calciumMinerals

Calcium

Also sold as: Elemental calcium · Calcium carbonate · Calcium citrate

An essential mineral for skeletal structure and cellular signaling. Supplements fill a dietary shortfall or a specific clinical need; fracture prevention depends strongly on population and baseline intake.

Anxiety

COMMUNITY_STACK_RATINGlive · n=0

Community

Not enough ratings yet: 0 of 10

Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.

+ Rate your experience (30 sec, anonymous)

NERD_PROTOCOL // EVIDENCE_MATRIXper goal

Research

AnxietyNo established evidence
  • Anxiety: General anxiety benefit is unestablished. Small PMS studies concern cycle-related psychological symptoms and do not demonstrate anxiety-disorder treatment.

REALITY CHECK // Calcium is not a universal fracture shield or fat burner. Bone-density gains are small, fracture results differ by setting and deficiency, and cardiovascular meta-analyses disagree. Favor meeting requirements from food and quantify a genuine shortfall before adding a supplement; K2 is not a proven insurance policy against arterial calcification.

Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.

Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.

CHECK_YOUR_BOTTLE.EXEruns in your browser · nothing is sent or stored

Check your bottle

Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.

Try a common label:
The label number is the…

Enter the amount from your label to see the result.

How it was studied

01 // STUDIED_DOSE_RANGE
Elemental amount matters
No single bone-trial interval is supplied. Pregnancy studies using at least 1 g/day belong under obstetric supervision.
02 // TIMING_&_MATRIX
Carbonate with food
Citrate is less dependent on stomach acid; smaller divided elemental amounts absorb more efficiently than large boluses.
03 // EVALUATION_WINDOW
Months to years, not days
Bone-density studies commonly span one to two years and fracture trials one to seven years; PMS research spans several cycles.
04 // SAFETY_&_QUALITY_GATE
Total intake and kidney history
Add dietary and supplemental calcium. Review hypercalcemia, stone history and medicines before use.

UPPER LIMIT // Dossier limits concern TOTAL intake from food and supplements: EFSA adult UL 2500 mg/day; US IOM/NIH UL 2500 mg/day at ages 19-50 and 2000 mg/day at age 51+. The US 1000 mg/day figure is an intake recommendation for some adults, not a UL. The numeric NIH display conservatively uses the 2000 mg older-adult limit; age-specific context remains essential.

NERD'S NOTENerd Protocols · a clinical and sports dietitian based in the EU

Summary

Increasing calcium intake produces a small, nonprogressive bone-density gain of about 0.6-1.8% over one to two years. A 33-RCT meta-analysis in 51145 community-dwelling older adults did not find clear fracture reduction; other syntheses report benefit, particularly in low-intake or institutionalized populations and with vitamin D. Conflicting cardiovascular findings and kidney-stone risk argue against indiscriminate supplementation.

Mechanism

Calcium is structural bone mineral and a signaling ion involved in muscle contraction and neurotransmission. Vitamin D supports intestinal absorption. Small changes in bone density do not establish clinically important fracture reduction. Vitamin K-dependent protein activation is mechanistically relevant but does not prove that K2 prevents supplement-related vascular events.

Typical studied dose

The dossier does not give a single complete dose interval for all bone trials. Pregnancy prevention trials included at least 1000 mg/day under obstetric supervision; this is not a self-use target. Single doses around 500 mg elemental calcium or less are more efficiently absorbed than large boluses. Carbonate is about 40% elemental calcium; citrate about 21%.

Upper limit

Dossier limits concern TOTAL intake from food and supplements: EFSA adult UL 2500 mg/day; US IOM/NIH UL 2500 mg/day at ages 19-50 and 2000 mg/day at age 51+. The US 1000 mg/day figure is an intake recommendation for some adults, not a UL. The numeric NIH display conservatively uses the 2000 mg older-adult limit; age-specific context remains essential.

POPULAR_STACKScombos with n ≥ 5

Popular stacks with Calcium

Not enough stack data yet. A combination with Calcium appears here once 5 people rate the same set.

> Rate my stack

Forms and label traps

Forms compared
Form on labelActive contentStudied range / dayAbsorption & GI toleranceVerdict
Calcium carbonate, approximately 40% elemental
Best for: A compact, low-cost salt taken with meals when appropriate.
 40% elemental / active no comparable trial range Requires adequate dissolution; food and gastric acid matter.
Constipation, bloating and gas are common limitations.		 Studied standard [DOSSIER // REFERENCE]
The percentage is chemical composition, not absorption. No universal trial target is set because the dossier lacks a complete shared interval.
Calcium citrate, approximately 21% elemental
Best for: People with low stomach acidity, acid suppression or relevant bariatric history.
 21% elemental / active no comparable trial range Less dependent on food or gastric acidity; comparison trials favor citrate in some contexts.
Generally gentler and less constipating than carbonate.		 Good option [DOSSIER // CHECK_FORM]
1000 mg salt is about 210 mg elemental calcium. Absorption differences must not be multiplied into elemental content.
Calcium lactate, approximately 13% elemental
Best for: Reading liquid or effervescent labels.
 13% elemental / active no comparable trial range Soluble; no superior clinical outcome is established here.
Generally tolerated in the source dossier.		 Good option [DOSSIER // CHECK_FORM]
Lactate is separated from gluconate; the source combined average 11% is not a real chemical conversion.
Calcium gluconate, approximately 9% elemental
Best for: Identifying low-density calcium salts.
 9% elemental / active no comparable trial range Soluble but low elemental density.
Generally tolerated in the source dossier.		 Good option [DOSSIER // CHECK_FORM]
Use actual formulation and label elemental amount; do not treat it as calcium lactate or assume an averaged percentage.
Citrate-malate, coral blends or hydroxyapatite products
Best for: Products with declared elemental calcium on the label.
 Unstandardized: active content unknown no comparable trial range Formulation-specific; superiority is not established for all niche forms.
Product-dependent; phosphate-containing products require kidney-disease review.		 Caution [DOSSIER // CHECK_FORM]
Variable ratios, hydration and matrices prevent a single fixed composition fraction. Coral calcium is principally carbonate and has no demonstrated premium clinical benefit.

Common label traps

  • TRAP_01 // CALCIUM PREVENTS FRACTURES IN EVERYONE
    Community-dwelling older-adult results are largely null; benefit is more plausible in low-intake, deficient or institutionalized groups.
  • TRAP_02 // CORAL CALCIUM IS SUPERIOR
    It is mainly calcium carbonate plus variable other material; the dossier provides no demonstrated clinical superiority.
  • TRAP_03 // K2 GUARANTEES CALCIUM AVOIDS ARTERIES
    Protein activation is a mechanism, not established protection against cardiovascular events.
  • TRAP_04 // CALCIUM BURNS FAT
    Cochrane and other randomized-trial syntheses found no meaningful weight-loss effect.
  • TRAP_05 // 1000 MG IS THE US UPPER LIMIT
    That number is an intake recommendation for some adults. US adult ULs are 2000 or 2500 mg depending on age.

Other outcomes studied

Outside the five leaderboard goals. Same evidence levels as above.

  • COMMUNITY-DWELLING FRACTURES Limited · no benefit
    A 33-RCT synthesis in 51145 adults aged at least 50 did not demonstrate clear reduction in hip or total fractures.
    PMID 29279934 PMID 29677308
  • LOW-INTAKE AND INSTITUTIONAL FRACTURES Limited · benefit
    Other syntheses report roughly 12% lower fracture risk with calcium or calcium plus D, and about 15% total and 30% hip-fracture reductions with Ca+D. Population, adherence and baseline status matter.
    PMID 17720017 PMID 26510847
  • BONE MINERAL DENSITY Strong · benefit
    Dietary or supplemental calcium increased BMD by about 0.6-1.8% over one to two years, a small nonprogressive effect unlikely by itself to yield major fracture prevention.
    PMID 26420598
  • POSTMENOPAUSAL OSTEOPOROSIS Limited · benefit
    Combined calcium plus vitamin D findings in women with osteoporosis cannot be generalized to calcium alone or replete healthy adults.
    PMID 41063100
  • PRE-ECLAMPSIA PREVENTION Limited · benefit
    Older syntheses reported about half the risk in relevant low-intake or high-risk pregnancy populations (RR about 0.45, CI about 0.31-0.65). Methodological criticism makes magnitude uncertain; obstetric supervision is required.
    PMID 30277579 PMID 35596262 PMID 38302677
  • BLOOD PRESSURE Limited · benefit
    An RCT meta-analysis found small average changes, about -1.9 mmHg systolic and -1.0 mmHg diastolic; this does not replace treatment.
    PMID 16673011
  • COLORECTAL CANCER ASSOCIATION Limited · benefit
    Prospective observational analyses associate an extra 300 mg/day with about 8-9% lower risk; confounding and absent causal trial confirmation prevent a prevention claim.
    PMID 24623471
  • WEIGHT LOSS Limited · no benefit
    Randomized-trial syntheses show no clinically meaningful weight-loss or body-composition benefit.
    PMID 38721870 PMID 26234296 PMID 21631515
  • PMS PSYCHOLOGICAL SYMPTOMS Limited · benefit
    Small and heterogeneous studies suggest possible cycle-related symptom improvement; this is not evidence for general anxiety treatment.
    PMID 38684926 PMID 19923637
  • CARDIOVASCULAR SAFETY SIGNAL Limited · makes it worse
    One synthesis reported myocardial-infarction HR about 1.27 (95% CI 1.01-1.59) with calcium alone. Other syntheses do not confirm increased risk; the controversy is unresolved and differs from dietary calcium.
    PMID 20671013 PMID 21505219 PMID 37743221 PMID 31625814 PMID 24035175
  • KIDNEY AND CALCIUM-ALKALI SAFETY Limited · makes it worse
    Stone context and high supplemental carbonate exposure require individualized assessment; excess can produce hypercalcemia, alkalosis and kidney injury.
    PMID 18845701 PMID 24288027

Reader questions

Do I need a calcium supplement?

First estimate dietary intake and any documented clinical need. More calcium does not continuously strengthen bones, and evidence in well-nourished community-dwelling adults is weak.

Does supplemental calcium cause heart attacks?

Meta-analyses disagree. Some show an increased-event signal and others do not; dedicated outcome trials are lacking. Discuss your baseline risk and actual intake gap with a clinician.

Carbonate or citrate?

Carbonate provides more elemental calcium per gram and is taken with food. Citrate is less acid-dependent and often better tolerated, but requires more compound mass for the same elemental amount.

Must I add K2 or use a fixed calcium-to-magnesium ratio?

Neither a universal 2:1 ratio nor guaranteed arterial protection with K2 is established in the dossier. Meet individual needs rather than forcing a marketed ratio.

How does calcium fit around thyroid medicine?

It can reduce levothyroxine absorption. The dossier advises at least four hours apart; use the medicine-specific schedule agreed with your clinician.

Stack interactions

  • Danger Levothyroxine [CAUTION // REVIEW_WITH_CLINICIAN]
    Calcium salts reduce thyroid-hormone absorption. The dossier advises at least four hours of separation; confirm with the medicine instructions and prescriber.
    PMID 10838651 PMID 21595516 PMID 28153426
  • Caution Tetracyclines, fluoroquinolones and bisphosphonates [CAUTION // REVIEW_WITH_CLINICIAN]
    Binding can reduce medicine absorption. Follow the specific medicine schedule; the dossier gives two-to-four-hour antibiotic spacing and separate fasting bisphosphonate administration.
  • Caution Thiazide diuretics and digoxin [CAUTION // REVIEW_WITH_CLINICIAN]
    Potential calcium elevation and related clinical risks require review and appropriate monitoring rather than an automatic supplement stack.
  • Caution Iron [CAUTION // REVIEW_WITH_CLINICIAN]
    Calcium can affect non-heme iron absorption. Consider separate supplements when iron deficiency is being treated; acute absorption changes do not prove long-term anemia in everyone.
    PMID 21462112
  • Caution Vitamin D and K2 [CAUTION // REVIEW_WITH_CLINICIAN]
    Vitamin D supports calcium absorption, while excess vitamin D may raise calcium. K2-related mechanisms do not establish protection from cardiovascular harm.
    PMID 30805347

Red flags: interactions and who should avoid it

Interactions

Calcium can reduce levothyroxine absorption; separate by at least four hours according to the treatment plan. Tetracycline and fluoroquinolone antibiotics require product-specific separation; bisphosphonates must be taken separately according to their instructions. Thiazides and digoxin require clinical review for calcium-related risks. Iron absorption can be affected; consider separate dosing, especially when treating anemia. Acid suppression can make carbonate less suitable than citrate.

Avoid or ask a doctor first if

Do not self-supplement with hypercalcemia, primary hyperparathyroidism, advanced kidney disease or granulomatous disease such as sarcoidosis. A calcium-stone history needs individualized dietary and timing advice; dietary calcium with meals is different from excess supplement use. Excess can cause constipation, nausea, weakness, increased urination, kidney injury and calcium-alkali syndrome. Pregnancy prevention is an obstetric intervention, not a home protocol.

Sources (PubMed, 33)

  1. Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis.
    PMID 29279934 · 2017 · systematic review and meta-analysis
    Null fracture findings in community-dwelling older adults, with population-specific applicability.
  2. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    PMID 29677308 · 2018 · systematic review and meta-analysis
    Primary-prevention fracture evidence review for community-dwelling adults.
  3. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.
    PMID 17720017 · 2007 · systematic review and meta-analysis
    Contrasting older-adult fracture and bone-loss benefit in mixed populations; baseline intake and setting matter.
  4. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
    PMID 26510847 · 2016 · systematic review and meta-analysis
    Calcium plus D fracture synthesis with benefit not interchangeable with calcium alone.
  5. Calcium intake and bone mineral density: systematic review and meta-analysis.
    PMID 26420598 · 2015 · systematic review and meta-analysis
    Small nonprogressive BMD increases with dietary or supplemental calcium.
  6. The effects of combined calcium and vitamin D supplementation on bone mineral density and fracture risk in postmenopausal women with osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
    PMID 41063100 · 2025 · systematic review and meta-analysis
    Combined calcium and vitamin D evidence specific to postmenopausal osteoporosis.
  7. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.
    PMID 30277579 · 2018 · systematic review and meta-analysis
    Pregnancy hypertensive-disorder prevention evidence, with larger effects in low-intake/high-risk settings.
  8. Calcium for pre-eclampsia prevention: A systematic review and network meta-analysis to guide personalised antenatal care.
    PMID 35596262 · 2022 · systematic review and meta-analysis
    Population-sensitive pre-eclampsia prevention synthesis.
  9. Calcium supplementation for the prevention of pre-eclampsia: Challenging the evidence from meta-analyses.
    PMID 38302677 · 2024 · systematic review and meta-analysis
    Methodological criticism of calcium pre-eclampsia meta-analytic estimates.
  10. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials.
    PMID 16673011 · 2006 · systematic review and meta-analysis
    Small average blood-pressure reduction in randomized trials.
  11. Calcium intake and colorectal cancer risk: dose-response meta-analysis of prospective observational studies.
    PMID 24623471 · 2014 · systematic review and meta-analysis
    Observational dose-response colorectal-cancer association, not causal prevention proof.
  12. Calcium supplementation for people with overweight or obesity.
    PMID 38721870 · 2024 · systematic review and meta-analysis
    Little or no clinically meaningful weight-loss benefit.
  13. Effect of increasing dietary calcium through supplements and dairy food on body weight and body composition: a meta-analysis of randomised controlled trials.
    PMID 26234296 · 2015 · systematic review and meta-analysis
    Null or negligible weight and body-composition findings.
  14. Efficacy of calcium supplementation for management of overweight and obesity: systematic review of randomized clinical trials.
    PMID 21631515 · 2011 · systematic review and meta-analysis
    Insufficient efficacy for overweight and obesity management.
  15. Effect of nutritional interventions on the psychological symptoms of premenstrual syndrome in women of reproductive age: a systematic review of randomized controlled trials.
    PMID 38684926 · 2025 · systematic review and meta-analysis
    Possible PMS psychological-symptom effects in small heterogeneous trials.
  16. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review.
    PMID 19923637 · 2009 · systematic review and meta-analysis
    Earlier PMS intervention synthesis with limited quality.
  17. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis.
    PMID 20671013 · 2010 · systematic review and meta-analysis
    Myocardial-infarction safety signal in calcium supplement synthesis.
  18. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis.
    PMID 21505219 · 2011 · systematic review and meta-analysis
    Cardiovascular-event signal in calcium with or without D reanalysis.
  19. Association Between Calcium Supplementation and the Risk of Cardiovascular Disease and Stroke: A&#xa0;Systematic Review and Meta-Analysis.
    PMID 37743221 · 2023 · systematic review and meta-analysis
    Later cardiovascular and stroke safety synthesis within an unresolved controversy.
  20. The Evidence and Controversy Between Dietary Calcium Intake and Calcium Supplementation and the Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Cohort Studies and Randomized Controlled Trials.
    PMID 31625814 · 2020 · systematic review and meta-analysis
    Distinguishes dietary-calcium and supplemental-calcium cardiovascular evidence.
  21. Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials.
    PMID 24035175 · 2013 · systematic review and meta-analysis
    Contrasting vascular-outcome synthesis without significant increased risk.
  22. Meta-analysis of calcium bioavailability: a comparison of calcium citrate with calcium carbonate.
    PMID 11329115 · 1999 · systematic review and meta-analysis
    Citrate-versus-carbonate absorption comparisons; composition and absorption are distinct.
  23. Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate.
    PMID 3213620 · 1988 · clinical study
    Dose-dependent calcium absorption, supporting attention to bolus size.
  24. A comparative study of calcium absorption following a single serving administration of calcium carbonate powder versus calcium citrate tablets in healthy premenopausal women.
    PMID 24772062 · 2014 · randomized controlled trial
    Formulation-specific single-serving carbonate-versus-citrate absorption study.
  25. Comparison of calcium citrate and calcium carbonate absorption in patients with a Roux-en-Y gastric bypass, sleeve gastrectomy, and one-anastomosis gastric bypass: a double-blind, randomized cross-over trial.
    PMID 39603923 · 2025 · randomized controlled trial
    Bariatric-surgery citrate-versus-carbonate absorption comparison.
  26. Comparison of the absorption of calcium carbonate and calcium citrate after Roux-en-Y gastric bypass.
    PMID 19437082 · 2009 · randomized controlled trial
    Roux-en-Y gastric-bypass absorption comparison.
  27. Effect of calcium carbonate on the absorption of levothyroxine.
    PMID 10838651 · 2000 · cohort study
    Calcium carbonate reduces levothyroxine absorption.
  28. Absorption of levothyroxine when coadministered with various calcium formulations.
    PMID 21595516 · 2011 · randomized controlled trial
    Levothyroxine absorption effects with multiple calcium salts.
  29. Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review.
    PMID 28153426 · 2017 · narrative review
    Review of factors affecting levothyroxine absorption.
  30. Calcium and iron absorption--mechanisms and public health relevance.
    PMID 21462112 · 2010 · laboratory study
    Review of calcium and iron absorption mechanisms and relevance; not a blanket long-term anemia claim.
  31. The Bone-Vasculature Axis: Calcium Supplementation and the Role of Vitamin K.
    PMID 30805347 · 2019 · narrative review
    Vitamin K and bone-vasculature mechanisms, not proof of cardiovascular-event prevention.
  32. Calcium supplementation and incident kidney stone risk: a systematic review.
    PMID 18845701 · 2008 · systematic review and meta-analysis
    Supplemental calcium and kidney-stone-risk review.
  33. Calcium-alkali syndrome in the modern era.
    PMID 24288027 · 2013 · narrative review
    Calcium-alkali syndrome review and excess-intake safety context.

Community comments

No approved comments yet. Comments are held for moderation.

+ Rate this